Free Trial

Jacobs Levy Equity Management Inc. Has $69.39 Million Stake in UiPath Inc. (NYSE:PATH)

UiPath logo with Business Services background

Jacobs Levy Equity Management Inc. grew its holdings in UiPath Inc. (NYSE:PATH - Free Report) by 35.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,459,071 shares of the company's stock after purchasing an additional 1,432,569 shares during the quarter. Jacobs Levy Equity Management Inc. owned about 0.99% of UiPath worth $69,385,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Jackson Creek Investment Advisors LLC acquired a new position in UiPath in the fourth quarter worth $298,000. ING Groep NV acquired a new position in UiPath in the fourth quarter worth $3,120,000. Pacer Advisors Inc. boosted its stake in UiPath by 698.1% in the fourth quarter. Pacer Advisors Inc. now owns 289,471 shares of the company's stock worth $3,679,000 after purchasing an additional 253,203 shares in the last quarter. Savant Capital LLC boosted its stake in UiPath by 483.1% in the fourth quarter. Savant Capital LLC now owns 225,906 shares of the company's stock worth $2,871,000 after purchasing an additional 187,161 shares in the last quarter. Finally, Washington Capital Management Inc. acquired a new position in UiPath in the fourth quarter worth $432,000. Institutional investors and hedge funds own 62.50% of the company's stock.

Insider Activity at UiPath

In other UiPath news, CAO Hitesh Ramani sold 12,500 shares of the business's stock in a transaction dated Thursday, April 3rd. The stock was sold at an average price of $10.19, for a total value of $127,375.00. Following the completion of the transaction, the chief accounting officer now directly owns 314,891 shares of the company's stock, valued at approximately $3,208,739.29. The trade was a 3.82% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Ashim Gupta sold 98,795 shares of the business's stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $12.01, for a total value of $1,186,527.95. Following the completion of the transaction, the chief financial officer now directly owns 987,322 shares of the company's stock, valued at approximately $11,857,737.22. The trade was a 9.10% decrease in their ownership of the stock. The disclosure for this sale can be found here. 22.37% of the stock is currently owned by corporate insiders.

UiPath Stock Down 0.3%

NYSE PATH traded down $0.04 on Wednesday, reaching $13.22. The company had a trading volume of 1,797,458 shares, compared to its average volume of 10,757,330. The stock's 50 day moving average is $11.13 and its 200-day moving average is $12.71. The stock has a market cap of $7.29 billion, a price-to-earnings ratio of -82.43 and a beta of 1.01. UiPath Inc. has a 52 week low of $9.38 and a 52 week high of $20.95.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on PATH shares. Mizuho reduced their price objective on UiPath from $12.00 to $11.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 15th. Barclays dropped their target price on UiPath from $15.00 to $12.00 and set an "equal weight" rating for the company in a research report on Thursday, March 13th. Scotiabank dropped their target price on UiPath from $15.00 to $12.00 and set a "sector perform" rating for the company in a research report on Thursday, March 13th. Royal Bank of Canada restated a "sector perform" rating and set a $13.00 target price on shares of UiPath in a research report on Wednesday, March 26th. Finally, Bank of America restated an "underperform" rating and set a $10.00 target price (down previously from $18.00) on shares of UiPath in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, UiPath presently has a consensus rating of "Hold" and a consensus target price of $12.72.

View Our Latest Report on UiPath

UiPath Company Profile

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

Read More

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
Top 3 Insider Stock Buys in April—Are They Still Good in May?
5 Blowout Earnings Winners That Could Soar Even Higher

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines